3852 J. Am. Chem. Soc., Vol. 121, No. 16, 1999
Simonsen et al.
(+)-(3R,5S)-5-tert-Butoxy-2,3-diphenylisoxazolidine (exo-6a) was
synthesized according to the general procedure on a 1.0-mmol scale
with catalyst 8b (10 mol %): yield 84%; ee ) 89%; semicrystalline
catalyst 8b (10 mol %): yield 79%; ee ) 91%; clear oil; [R]D ) +217.3
1
(c 1.0, CHCl3). H NMR9c 13C NMR δ 15.2, 46.8, 63.6, 69.2, 100.6,
116.6, 122.5, 127.4, 127.6, 128.5, 128.8, 141.4, 150.3. HPLC (Daicel
Chiralcel OD, hexane/i-PrOH ) 99:1, flow rate ) 1.0 mL/min) tr )
11.2 min (minor), tr ) 25.3 min (major). HRMS (EI) calcd for C17H19-
NO2 (M+) 269.1415, found 269.1402.
1
solid; [R]D ) +160.9 (c 1.0, CHCl3). H NMR δ 1.39 (s, 9H), 2.34
(ddd, J ) 3.3, 6.8, and 12.9 Hz, 1H), 2.97 (ddd, J ) 6.0, 9.3, and 13.2
Hz, 1H), 4.42 (dd, J ) 7.0 and 9.0 Hz, 1H), 5.65 (dd, J ) 3.3 and 6.1
Hz, 1H), 6.93 (m, 2H), 7.15-7.38 (m, 6H), 7.56 (m, 2H). 13C NMR δ
28.9, 47.0, 68.9, 75.1, 96.4, 115.7, 121.9, 127.3, 127.4, 128.5, 128.7,
142.0, 150.9. HPLC (Daicel Chiralcel OD, hexane/i-PrOH ) 99:1, flow
rate ) 0.7 mL/min) tr ) 12.2 min (minor), tr )23.6 min (major). HRMS
(EI) calcd for C19H23NO2 (M+) 297.1723, found 297.1732.
(+)-(3R,5S)-5-Ethoxy-3-(4-methylphenyl)-2-phenylisoxazoli-
dine (exo-6f) was synthesized according to the general procedure on a
2-mmol scale with catalyst 8b (10 mol %): yield 70%; ee ) 90%;
1
[R]D ) +171.2 (c 1.0, CHCl3). H NMR δ 1.34 (t, J ) 7.2 Hz, 3H),
2.37 (s, 3H), 2.40 (ddd, J ) 2.4, 7.2, and 13.2 Hz, 1H), 3.04 (ddd, J
) 6.0, 9.3, and 13.2 Hz, 1H), 3.65 (dq, J ) 7.2 and 9.8 Hz, 1H), 4.04
(dq, J ) 7.2 and 9.3 Hz, 1H), 4.30 (dd, J ) 6.6 and 9.3 Hz, 1H), 5.38
(dd, J ) 2.4 and 6.0 Hz, 1H), 6.92-7.02 (m, 3H), 7.14-7.25 (m, 4H),
7.44 (d, J ) 8.1 Hz, 2h). 13C NMR δ 15.2, 21.4, 47.0, 63.6, 69.1,
100.6, 116.7, 122.5, 127.4, 128.5, 129.5, 137.2, 138.2, 150.3. HPLC
(Daicel Chiralcel OD, hexane/i-PrOH ) 99:1, flow rate ) 1.0 mL/
min) tr ) 5.3 min (minor), tr ) 12.2 min (major). HRMS (EI) calcd
for C18H21NO2 (M+) 283.1572, found 283.1752.
(+)-(3R,5R)-5-tert-Butoxy-2,3-diphenylisoxazolidine (endo-6a) was
synthesized according to the general procedure on a 0.5-mmol scale
using BINOL 7b and AlMe2Cl (10 mol %) as the catalyst: yield 40%;
1
ee ) 26.6%; semicrystalline solid; [R]D ) +4.4 (c 1.0, CHCl3). H
NMR δ 1.26 (s, 9H), 2.50 (ddd, J ) 5.1, 9.3, and 12.2 Hz, 1H), 2.63
(ddd, J ) 1.5, 6.9, and 12.1 Hz, 1H), 4.81 (dd, J ) 6.6 and 9.3 Hz,
1H), 5.65 (br. d, J ) 4.2 Hz, 1H), 6.88 (t, J ) 7.0 Hz, 1H), 6.98 (d, J
) 7.8 Hz, 2H), 7.14-7.40 (m, 5H), 7.49 (d, J ) 7.2 Hz, 2H). 13C
NMR δ 28.8, 47.5, 67.5, 74.9, 97.1, 115.5, 121.1, 126.5, 127.4, 128.2,
128.8, 141.6, 152.4. HPLC (Daicel Chiralcel OD, hexane/i-PrOH )
99.5:0.5, flow rate ) 0.7 mL/min) tr ) 31.0 min (minor), tr ) 33.5
min (major). HRMS (EI) calcd for C19H23NO2 (M+) 297.1723, found
297.1738.
(+)-(3R,5S)-3-(4-Chlorophenyl)-5-ethoxy-2-phenylisoxazolidine
(exo-6 g) was synthesized according to the general procedure on a
1-mmol scale with catalyst 8b (10 mol %): yield 78%; ee ) 94%;
1
[R]D ) +210.5 (c 1.0, CHCl3). H NMR δ 1.31 (t, J ) 7.2 Hz, 3H),
2.34 (ddd, J ) 2.1, 6.6, and 13.2 Hz, 1H), 3.02 (ddd, J ) 6.0, 9.9, and
13.2 Hz, 1H), 3.64 (dq, J ) 7.2 and 9.6 Hz, 1H), 4.01 (dq, J ) 7.2 and
9.9 Hz, 1H), 4.33 (dd, J ) 6.6 and 9.6 Hz, 1H), 5.39 (dd, J ) 2.1 and
6.0 Hz, 1H), 6.90-7.02 (m, 3H), 7.18-7.25 (m, 2H), 7.35 (d, J ) 8.1
Hz, 2h), 7.49 (d, J ) 8.1 Hz, 2H). 13C NMR δ 15.2, 46.5, 63.6, 68.4,
100.6, 116.4, 122.6, 128.6, 128.8, 128.9, 133.3, 140.2, 150.1. HPLC
(Daicel Chiralcel OD, hexane/i-PrOH ) 99.5:0.5, flow rate ) 0.7 mL/
min) tr ) 13.1 min (minor), tr ) 14.1 min (major). HRMS (EI) calcd
for C17H18ClNO2 (M+) 303.1026, found 303.1042.
(+)-(3R,5S)-5-tert-Butoxy-3-(4-methylphenyl)-2-phenylisoxazoli-
dine (exo-6b) was synthesized according to the general procedure on
a 1.0-mmol scale with catalyst 8b (10 mol %): yield 71%; ee ) 81%;
clear oil; [R]D ) +145.4 (c 1.0, CHCl3). 1H NMR δ 1.42 (s, 9H), 2.36
(ddd, J ) 3.3, 7.2, and 13.2 Hz, 1H), 2.40 (s, 3H), 2.99 (ddd, J ) 6.0,
9.3, and 12.9 Hz, 1H), 4.40 (dd, J ) 7.2 and 8.7 Hz, 1H), 5.67 (dd, J
) 3.3 and 6.0 Hz, 1H), 6.90-7.05 (m, 3H), 7.16-7.25 (m, 4H), 7.49
(d, J ) 7.8 Hz, 2H). 13C NMR δ 21.2, 29.0, 47.4, 68.8, 75.0, 96.2,
115.8, 121.8, 127.2, 128.5, 129.4, 137.0, 138.9, 151.0. HPLC (Daicel
Chiralcel OD, hexane/i-PrOH ) 99:1, flow rate ) 1.0 mL/min) tr )
7.0 min (minor), tr ) 11.6 min (major). HRMS (EI) calcd for C20H25-
NO2 (M+) 311.1885, found 311.1899.
(+)-(3R,5S)-5-Ethoxy-3-(4-methoxyphenyl)-2-phenylisoxazoli-
dine (exo-6h) was synthesized according to the general procedure on
a 0.5-mmol scale with catalyst 8b (10 mol %): yield 50%; ee ) 88%;
1
[R]D ) +145.7 (c 1.0, CHCl3). H NMR δ 1.32 (t, J ) 7.2 Hz, 3H),
2.37 (ddd, J ) 2.1, 7.2, and 13.2 Hz, 1H), 3.01 (ddd, J ) 6.0, 9.3, and
13.2 Hz, 1H), 3.63 (dq, J ) 7.2 and 9.9 Hz, 1H), 3.82 (s, 3H), 4.01
(dq, J ) 7.2 and 9.3 Hz, 1H), 4.25 (dd, J ) 7.2 and 9.3 Hz, 1H), 5.37
(dd, J ) 2.1 and 6.0 Hz, 1H), 6.91 (d, J ) 9.0 Hz, 2H), 6.97 (d, J )
7.8 Hz, 2H), 7.16-7.22 (m, 3H), 7.44 (d, J ) 9.0 Hz, 2H). 13C NMR
δ 15.2, 46.9, 55.3, 63.6, 69.0, 100.6, 114.1, 116.8, 122.6, 124.3, 128.5,
128.7, 150.3, 160.1. HPLC (Daicel Chiralcel OD, hexane/i-PrOH )
99:1, flow rate ) 1.0 mL/min) tr ) 7.4 min (minor), tr ) 13.5 min
(major). HRMS (EI) calcd for C18H21NO3 (M+) 299.1521, found
299.1536.
(+)-(3R,5S)-5-Benzyloxy-3-(4-chlorophenyl)-2-phenylisoxazoli-
dine (exo-6i) was synthesized according to the general procedure on a
0.2-mmol scale with catalyst 8b (10 mol %): yield 68%; ee ) 85%.
1H NMR δ 2.41 (ddd, J ) 1.5, 6.0, and 13.2 Hz, 1H), 3.03 (ddd, J )
5.8, 9.4, and 13.2 Hz, 1H), 4.33 (dd, J ) 6.0 and 9.9 Hz, 1H), 4.68 (d,
J ) 12 Hz, 1H), 4.98 (d, J ) 12 Hz, 1H), 5.44 (dd, J ) 1.5 and 6.0
Hz, 1H), 6.90-7.02 (m, 3H), 7.18-7.45 (m, 9H), 7.48 (d, J ) 9.0 Hz,
2H). HPLC (Daicel Chiralcel OD, hexane/i-PrOH ) 99:1, flow rate )
0.7 mL/min) tr ) 12.9 min (minor), tr ) 15.3 min (major). HRMS (EI)
calcd for C22H20ClNO2 (M+) 365.1182, found 365.1211.
(+)-(3R,5S)-5-tert-Butoxy-3-(4-chlorophenyl)-2-phenylisoxazoli-
dine (exo-6c) was synthesized according to the general procedure on
a 1.0-mmol scale with catalyst 8b (10 mol %): yield 74%; ee ) 78%;
clear oil; [R]D ) +145.8 (c 1.0, CHCl3). 1H NMR δ 1.37 (s, 9H), 2.27
(ddd, J ) 3.0, 6.1, and 13.2 Hz, 1H), 2.95 (ddd, J ) 6.0, 9.3, and 12.6
Hz, 1H), 4.40 (dd, J ) 6.0 and 9.3 Hz, 1H), 5.66 (dd, J ) 3.3 and 6.0
Hz, 1H), 6.90-7.00 (m, 3H), 7.16-7.25 (m, 2H), 7.34 (d, J ) 8.6 Hz,
2H), 7.52 (d, J ) 8.5 Hz, 2H). 13C NMR δ 28.9, 46.8, 68.1, 75.1, 96.3,
115.5, 122.0, 128.6, 128.7, 128.8, 133.1, 140.7, 150.6. HPLC (Daicel
Chiralcel OD, hexane/i-PrOH ) 99:1, flow rate ) 1.0 mL/min) tr )
5.7 min (minor), tr ) 7.0 min (major). HRMS (EI) calcd for C19H22-
ClNO2 (M+) 331.1339, found 331.1325.
1
endo-6c: Yield 10%; ee ) 0%; clear oil; H NMR δ 1.25 (s, 9H),
2.44 (ddd, J ) 5.1, 9.3, and 12.5 Hz, 1H), 2.61 (ddd, J ) 1.8, 7.2, and
12.2 Hz, 1H), 4.78 (dd, J ) 6.6 and 9.3 Hz, 1H), 5.62 (br. d, J ) 4.5
Hz, 1H), 6.85-6.98 (m, 3H), 7.14-7.22 (m, 2H), 7.32 (d, J ) 8.4 Hz,
2H), 7.42 (d, J ) 8.1 Hz, 2H). 13C NMR δ 28.8, 47.4, 66.9, 75.0, 97.0,
115.5, 121.4, 127.9, 128.3, 128.9, 133.1, 140.1, 152.1. HPLC (Daicel
Chiralcel OD, hexane/i-PrOH ) 99:1, flow rate ) 1.0 mL/min) tr )
11.7 min, tr ) 13.8 min (major). HRMS (EI) calcd for C19H22ClNO2
(M+) 331.1339, found 331.1321.
(rac)-2,3,3a,4,5,6a-Hexahydro-2,3-diphenylfuro[3,2-d]isoxazoli-
dine (exo-6j) was synthesized according to the general procedure on a
0.5-mmol scale with catalyst 8b (10 mol %): yield 51%; ee ) <5%;
clear oil; 1H NMR.26 13C NMR δ 28.3, 53.5, 69.3, 71.0, 105.3, 119.2,
123.7, 127.4, 127.7, 128.4, 128.8, 137.8, 148.8. HPLC (Daicel Chiralcel
OD, hexane/i-PrOH ) 98:2, flow rate ) 1.0 mL/min) tr ) 12.5 min
(minor), tr ) 18.6 min (major). HRMS (EI) calcd for C17H17NO2 (M+)
267.1259, found 267.1281.
(+)-(3R,5S)-5-tert-Butoxy-3-(4-methoxyphenyl)-2-phenylisoxazo-
lidine (exo-6d) was synthesized according to the general procedure
on a 1.0-mmol scale with catalyst 8b (10 mol %): yield 65%; ee )
1
77%; clear oil; [R]D ) +141.6 (c 1.0, CHCl3). H NMR δ 1.38 (s,
9H), 2.32 (ddd, J ) 3.3, 7.2, and 12.6 Hz, 1H), 2.95 (ddd, J ) 6.0,
9.0, and 13.0 Hz, 1H), 3.81 (s, 3H), 4.35 (dd, J ) 7.2 and 8.7 Hz, 1H),
5.64 (dd, J ) 3.3 and 6.0 Hz, 1H), 6.88-7.0 (m, 5H), 7.19 (t, J ) 7.9
Hz, 2H), 7.46 (t, J ) 8.4 Hz, 2H). 13C NMR δ 29.0, 47.3, 55.3, 68.6,
75.0, 96.2, 114.1, 115.9, 121.8, 128.5, 133.8, 150.9, 159.0. HPLC
(Daicel Chiralcel OD, hexane/i-PrOH ) 99:1, flow rate ) 1.0 mL/
min) tr ) 10.1 min (minor), tr ) 13.3 min (major). HRMS (EI) calcd
for C20H25NO3 (M+) 327.1834, found 327.1851.
(endo-6j): Yield 12%; ee ) 0%; clear oil; 1H NMR.26 HPLC (Daicel
Chiralcel OD, hexane/i-PrOH ) 98:2, flow rate ) 1.0 mL/min) tr )
10.1 min (minor), tr ) 13.3 min (major). HRMS (EI) calcd for C17H17-
NO2 (M+) 267.1259, found 267.1278.
(rac)-2,3,5-Triphenylisoxazolidine (exo-6k) was synthesized ac-
cording to the general procedure on a 0.5-mmol scale with catalyst 8b
(+)-(3R,5S)-5-Ethoxy-2,3-diphenylisoxazolidine (exo-6e) was syn-
thesized according to the general procedure on a 0.5-mmol scale with
(26) Paul, R.; Tchelitcheff, S. Bull. Soc. Chim. Fr. 1967, 4179.